Read the Blog
If you work in, or around, the early phase drug development landscape, you are likely aware of the requirements for an investigational new drug (IND) package.
Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.
Related Press Release
Altasciences announced the addition of Paul Sidney to their Compliance and Regulatory Affairs team as Senior Director.
Safety assessments for both small and large molecules
Clinical pharmacology trials from first-in-human to end of Phase II
As part of our full service offering or as standalone solutions
Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.
